Literature DB >> 34915608

Extending the stroke treatment window beyond DAWN in patients with very slow progressor type collaterals: How far can we go?

Igor Pagiola1,2,3, Olivier Chassin4, Sophie Gallas1, Mariana Sarov Riviere4, Nicolas Legris4, Cristian Mihalea1, Jildaz Caroff1, Leon Ikka1, Vanessa Chalumeau1, Guilherme Brasileiro de Aguiar1, Augustin Ozanne1, Jacques Moret1, Christian Denier4, Laurent Spelle1.   

Abstract

Five trials published in 2015 showed the benefit of endovascular thrombectomy (ET) in patients with stroke and large vessel occlusion, extending the treatment window has become an obsession of all physicians. In 2018, the DAWN and DEFUSE-3 trials showed that, with careful selection of patients, the procedure could be carried out up to 24 hours after symptom onset with good outcomes. In addition, there have been cases where the DAWN criteria were met, and treatment occurred >24 hours after symptom onset. We present the case of a 68-year-old female whose groin puncture occurred 52 hours after the time last known well (TLKW), after neurological worsening of the initial situation, with a large mismatch ratio observed on magnetic resonance imaging, achieving TICI (the Thrombolysis in Cerebral Infarction scale) grade 3 recanalization. Five days after the procedure, the patient was discharged with NIHSS (National Institutes of Health Stroke Scale) score of 3. Some types of collateral circulation (slow progressors and "turtle" progressors, our term for very slow progressors) can extend the treatment window beyond 24 hours of the TLKW but can lead to a hyperperfusion-like syndrome immediately after the ET. Further studies are needed to evaluate the reproducibility of this hypothetical syndrome.

Entities:  

Keywords:  Cerebral blood flow; Collateral circulation; Endovascular treatment; Large vessel occlusion; Mechanical thrombectomy; Stroke

Year:  2021        PMID: 34915608      PMCID: PMC8743825          DOI: 10.7461/jcen.2021.E2021.01.003

Source DB:  PubMed          Journal:  J Cerebrovasc Endovasc Neurosurg        ISSN: 2234-8565


INTRODUCTION

The treatment of stroke patients with large vessel occlusion (LVO) has completely changed after five randomized controlled trials demonstrated the superiority of endovascular thrombectomy (ET) over medical management within the first 6 hours of symptoms [3,4,8,10,13]. The importance of extending the therapeutic window for stroke has been known since 2008 [9]. In 2018, the DAWN [11] and DEFUSE-3 trials [2] demonstrated the effectiveness of ET 6-24 hours from the time last known well (TLKW) in selected patients with mismatch between the clinical deficit severity and infarct core volume. The type of collateral circulation in each patient can lead to either a large or small ischemic core. Patients in whom a large ischemic core is observed, have a “faster progressor” type; those with a small core have a “slow progressor” type, in which good collaterals are maintained [9]. The type of collateral circulation and consequently the rate of progression can influence the volume of ischemic core and the effectiveness of ET in patients beyond the conventional time window. There are case series [7] and case reports [1,14] showing good outcomes in patients treated beyond the 24-hour limits of the DAWN trial. The aim of this article is to report the case of a patient who underwent ET 52 hours after the onset of symptoms, who evolved with significant neurological improvement, despite a possible hyperperfusion-like syndrome. We also conducted a brief literature review on the topic.

CASE REPORT

A 68-year-old female previously modified Rankin Scale 0 developed mild aphasia with an unknown TLKW; her daughter first observed this in the morning, while talking on the phone with the patient. Seven hours after that, the daughter visited the patient at home; the mild aphasia persisted and so they went to the hospital. The NIHSS (National Institutes of Health Stroke Scale) score at admission was 4. Computed tomography (CT) angiography revealed a left M1 occlusion (Fig. 1). Because of the low NIHSS score and almost 7 hours after the ictus, no venous thrombolysis or interventional treatment was proposed. At that time, aspirin was prescribed.
Fig. 1.

Cranial CT angiography showing a left M1 occlusion (yellow arrow in A and B) with good collateral circulation to the left cerebral hemisphere (C). A–coronal view; B and C–axial view. CT, computed tomography.

Fifty-one hours after the TLKW, the patient had an NIHSS score of 11; a perfusion magnetic resonance imaging (MRI) revealed an ischemic core volume of 8 ml with a large mismatch ratio observed, and therefore, an ET was proposed (Fig. 2).
Fig. 2.

MRI and perfusion MRI at 51 hours after TLKW and endovascular thrombectomy 52 hours after TLKW. MRI before endovascular treatment DWI (A), FLAIR (B) and perfusion (C), Left ICA DSA image before mechanical thrombectomy Anteriorposterior (D), and after one pass of ADAPT (E). MRI, magnetic resonance imaging; TLKW, time last known well; DWI, diffusion-weighted imaging; FLAIR, fluid-attenuated inversion recovery; ICA, internal carotid artery; DSA, digital subtraction angiography; ADAPT, a direct-aspiration first-pass technique.

Groin puncture occurred 52 hours after the TLKW; subsequently a direct-aspiration first-pass technique (ADAPT) was used and one pass resulted in a thrombolysis in cerebral infarction scale (TICI) grade 3 recanalization. The day after the procedure, an NIHSS score of 16 was observed; no hemorrhagic signals were detected by CT. Five days after the procedure, the patient had an NIHSS score of 3 with a mild dysarthria and partial facial palsy. She was discharged to another hospital. The patient is followed up on an outpatient basis. In the 6-month evaluation, the patient still presents with an NIHSS score of 2, being capable of self-care (Modified Rankin Scale 2).

DISCUSSION

This kind of case raises a huge discussion about whether patients can be treated outside of the standard therapeutic window and whether the type of collateral circulation can extend this window. It is already known that <30% [6] of patients with LVO have a “slow progressor” type and can benefit substantially from ET after 8 hours. This was demonstrated in the DAWN [11] and DEFUSE-3 [2] trials. Our case presents that some patients might have a very slow progressor type, which we name “turtle” progressor type. These patients could possibly benefit from ET beyond the DAWN trial criteria (>24 hours) in highly selected cases. This progressor type might exist where there is an exceptional capacity to sustain collateral blood flow, and where the ischemic core does not become enlarged, protecting the penumbra area. Another interesting point which is seen in this case is a major worsening the day after treatment (NIHSS score of 11 to 16) without hemorrhagic transformation despite successful endovascular treatment (TICI 3). In addition to the Contrast-induced encephalopathy already described by some authors [5], it could be that patients with the slow progressor type, and in our case the “turtle” progressor type, may suffer a cerebral hyperperfusion-like syndrome when a TICI grade 3 recanalization is achieved after LVO. Because recanalization changes the low-pressure cerebral flow in the microcirculation (collateral flow) to a high-pressure flow, a hyperperfusion-like syndrome that we call “collateral syndrome” could occur. This event needs to be evaluated in other patients with the collateral profile of slow progressor and “turtle” progressor to analyze the reproducibility of this kind of “collateral syndrome”.

CONCLUSIONS

This is a rare case demonstrating a very late thrombectomy 52 hours after the TLKW with a good recovery observed 5 days after the procedure. In some cases, there appears to be a direct relationship between some types of collateral circulation (slow progressor and “turtle” progressor) and extension of the treatment window. Patients with these progressor types can experience a hyperperfusion-like syndrome (“collateral syndrome”) after the recanalization of an LVO, which can lead to clinical worsening in the 48 hours immediately after the ET. However, further studies are needed in order to evaluate the reproducibility of this hypothetical syndrome.
  14 in total

1.  Fast Versus Slow Progressors of Infarct Growth in Large Vessel Occlusion Stroke: Clinical and Research Implications.

Authors:  Marcelo Rocha; Tudor G Jovin
Journal:  Stroke       Date:  2017-08-09       Impact factor: 7.914

2.  Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.

Authors:  Gregory W Albers; Michael P Marks; Stephanie Kemp; Soren Christensen; Jenny P Tsai; Santiago Ortega-Gutierrez; Ryan A McTaggart; Michel T Torbey; May Kim-Tenser; Thabele Leslie-Mazwi; Amrou Sarraj; Scott E Kasner; Sameer A Ansari; Sharon D Yeatts; Scott Hamilton; Michael Mlynash; Jeremy J Heit; Greg Zaharchuk; Sun Kim; Janice Carrozzella; Yuko Y Palesch; Andrew M Demchuk; Roland Bammer; Philip W Lavori; Joseph P Broderick; Maarten G Lansberg
Journal:  N Engl J Med       Date:  2018-01-24       Impact factor: 91.245

3.  Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.

Authors:  Raul G Nogueira; Ashutosh P Jadhav; Diogo C Haussen; Alain Bonafe; Ronald F Budzik; Parita Bhuva; Dileep R Yavagal; Marc Ribo; Christophe Cognard; Ricardo A Hanel; Cathy A Sila; Ameer E Hassan; Monica Millan; Elad I Levy; Peter Mitchell; Michael Chen; Joey D English; Qaisar A Shah; Frank L Silver; Vitor M Pereira; Brijesh P Mehta; Blaise W Baxter; Michael G Abraham; Pedro Cardona; Erol Veznedaroglu; Frank R Hellinger; Lei Feng; Jawad F Kirmani; Demetrius K Lopes; Brian T Jankowitz; Michael R Frankel; Vincent Costalat; Nirav A Vora; Albert J Yoo; Amer M Malik; Anthony J Furlan; Marta Rubiera; Amin Aghaebrahim; Jean-Marc Olivot; Wondwossen G Tekle; Ryan Shields; Todd Graves; Roger J Lewis; Wade S Smith; David S Liebeskind; Jeffrey L Saver; Tudor G Jovin
Journal:  N Engl J Med       Date:  2017-11-11       Impact factor: 91.245

4.  Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.

Authors:  Jeffrey L Saver; Mayank Goyal; Alain Bonafe; Hans-Christoph Diener; Elad I Levy; Vitor M Pereira; Gregory W Albers; Christophe Cognard; David J Cohen; Werner Hacke; Olav Jansen; Tudor G Jovin; Heinrich P Mattle; Raul G Nogueira; Adnan H Siddiqui; Dileep R Yavagal; Blaise W Baxter; Thomas G Devlin; Demetrius K Lopes; Vivek K Reddy; Richard du Mesnil de Rochemont; Oliver C Singer; Reza Jahan
Journal:  N Engl J Med       Date:  2015-04-17       Impact factor: 91.245

5.  Thrombectomy within 8 hours after symptom onset in ischemic stroke.

Authors:  Tudor G Jovin; Angel Chamorro; Erik Cobo; María A de Miquel; Carlos A Molina; Alex Rovira; Luis San Román; Joaquín Serena; Sonia Abilleira; Marc Ribó; Mònica Millán; Xabier Urra; Pere Cardona; Elena López-Cancio; Alejandro Tomasello; Carlos Castaño; Jordi Blasco; Lucía Aja; Laura Dorado; Helena Quesada; Marta Rubiera; María Hernandez-Pérez; Mayank Goyal; Andrew M Demchuk; Rüdiger von Kummer; Miquel Gallofré; Antoni Dávalos
Journal:  N Engl J Med       Date:  2015-04-17       Impact factor: 91.245

6.  Endovascular therapy for ischemic stroke with perfusion-imaging selection.

Authors:  Bruce C V Campbell; Peter J Mitchell; Timothy J Kleinig; Helen M Dewey; Leonid Churilov; Nawaf Yassi; Bernard Yan; Richard J Dowling; Mark W Parsons; Thomas J Oxley; Teddy Y Wu; Mark Brooks; Marion A Simpson; Ferdinand Miteff; Christopher R Levi; Martin Krause; Timothy J Harrington; Kenneth C Faulder; Brendan S Steinfort; Miriam Priglinger; Timothy Ang; Rebecca Scroop; P Alan Barber; Ben McGuinness; Tissa Wijeratne; Thanh G Phan; Winston Chong; Ronil V Chandra; Christopher F Bladin; Monica Badve; Henry Rice; Laetitia de Villiers; Henry Ma; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis
Journal:  N Engl J Med       Date:  2015-02-11       Impact factor: 91.245

7.  A randomized trial of intraarterial treatment for acute ischemic stroke.

Authors:  Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Lucie A van den Berg; Hester F Lingsma; Albert J Yoo; Wouter J Schonewille; Jan Albert Vos; Paul J Nederkoorn; Marieke J H Wermer; Marianne A A van Walderveen; Julie Staals; Jeannette Hofmeijer; Jacques A van Oostayen; Geert J Lycklama à Nijeholt; Jelis Boiten; Patrick A Brouwer; Bart J Emmer; Sebastiaan F de Bruijn; Lukas C van Dijk; L Jaap Kappelle; Rob H Lo; Ewoud J van Dijk; Joost de Vries; Paul L M de Kort; Willem Jan J van Rooij; Jan S P van den Berg; Boudewijn A A M van Hasselt; Leo A M Aerden; René J Dallinga; Marieke C Visser; Joseph C J Bot; Patrick C Vroomen; Omid Eshghi; Tobien H C M L Schreuder; Roel J J Heijboer; Koos Keizer; Alexander V Tielbeek; Heleen M den Hertog; Dick G Gerrits; Renske M van den Berg-Vos; Giorgos B Karas; Ewout W Steyerberg; H Zwenneke Flach; Henk A Marquering; Marieke E S Sprengers; Sjoerd F M Jenniskens; Ludo F M Beenen; René van den Berg; Peter J Koudstaal; Wim H van Zwam; Yvo B W E M Roos; Aad van der Lugt; Robert J van Oostenbrugge; Charles B L M Majoie; Diederik W J Dippel
Journal:  N Engl J Med       Date:  2014-12-17       Impact factor: 91.245

8.  Randomized assessment of rapid endovascular treatment of ischemic stroke.

Authors:  Mayank Goyal; Andrew M Demchuk; Bijoy K Menon; Muneer Eesa; Jeremy L Rempel; John Thornton; Daniel Roy; Tudor G Jovin; Robert A Willinsky; Biggya L Sapkota; Dar Dowlatshahi; Donald F Frei; Noreen R Kamal; Walter J Montanera; Alexandre Y Poppe; Karla J Ryckborst; Frank L Silver; Ashfaq Shuaib; Donatella Tampieri; David Williams; Oh Young Bang; Blaise W Baxter; Paul A Burns; Hana Choe; Ji-Hoe Heo; Christine A Holmstedt; Brian Jankowitz; Michael Kelly; Guillermo Linares; Jennifer L Mandzia; Jai Shankar; Sung-Il Sohn; Richard H Swartz; Philip A Barber; Shelagh B Coutts; Eric E Smith; William F Morrish; Alain Weill; Suresh Subramaniam; Alim P Mitha; John H Wong; Mark W Lowerison; Tolulope T Sajobi; Michael D Hill
Journal:  N Engl J Med       Date:  2015-02-11       Impact factor: 91.245

9.  Existence of the diffusion-perfusion mismatch within 24 hours after onset of acute stroke: dependence on proximal arterial occlusion.

Authors:  William A Copen; Leila Rezai Gharai; Elizabeth R Barak; Lee H Schwamm; Ona Wu; Shahmir Kamalian; R Gilberto Gonzalez; Pamela W Schaefer
Journal:  Radiology       Date:  2009-01-21       Impact factor: 11.105

10.  Endovascular Thrombectomy in Acute-Onset Ischemic Stroke - beyond the Standard Time Windows: A Case Report and a Review of the Literature.

Authors:  Conan So; Naveed Chaudhry; Dheeraj Gandhi; John W Cole; Melissa Motta
Journal:  Case Rep Neurol       Date:  2018-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.